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Objective: To assess the clinical signiﬁcance of low compliance bladder (LCB) in women with lower
urinary tract symptoms.
Materials and Methods: Medical records of 1490 women undergoing videourodynamic studies (VUSs)
were reviewed. Comprehensive medical histories, physical examinations, bladder diaries, and results of
multichannel VUS were analyzed. This study adopted an end ﬁlling detrusor pressure (EFP) greater than
20 cmH2O to deﬁne LCB.
Results: Among the study patients (n ¼ 1490), 9.1% were diagnosed with LCB using a cutoff value of 17.5
cmH2O, which had a sensitivity and speciﬁcity of 89% and 92.7%, respectively. Results of multivariate
analysis indicated that age (p ¼ 0.005), maximum cystometric capacity (MCC; p ¼ 0.002), detrusor
overactivity (DO; p ¼ 0.001), pelvic organ prolapse (POP; p ¼ 0.018), recurrent urinary tract infection
(p ¼ 0.001), and radical abdominal hysterectomy (RAH; p < 0.001) as independent prognostic factors.
Furthermore, our study results indicate that the MCC, urinary tract infection, and a history of RAH have a
positive correlation with LCB, whereas, age, POP, and DO have a negative correlation with LCB.
Conclusion: Our idea using EFP (17.5 cmH2O) for screening women with LCB is feasible for clinical use.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
The functions of urinary bladder are not only storage of urine
and emptying but at a higher level, also maintaining the relatively
low intravesical pressure [1]. An increase in intravesical pressure,
for whatever reason, is universally accepted to be a major factor in
disorders of compliance and as clinical experience has demon-
strated increased intravesical pressure plays a major role in dete-
rioration of the upper urinary tract and the appearance of voiding
disorders with severe repercussion on quality of life [2].
Bladder compliance, which describes the relationship between
change in bladder volume and change in detrusor pressure (DV/DP)
[3], is generally regarded as ameasure of bladder dispensability andnd Gynecology, Chang Gung
of Chang Gung School of
, Taiwan.
g).
bstetrics & Gynecology. Publishedthe key determinant of the upper urinary tract deterioration in
clinical interpretation. Decrease of the compliance may be seen in
some pathological conditions such as infection or ﬁbrosis (e.g., ra-
diation, Foley indwelling, obstructive uropathy, or neurogenic
bladder). At present, this is no golden standard to diagnose low
compliance bladder (LCB) in women and this is the primary reason
for conducting this study. The normal range for bladder compliance
in adults has not yet been validated and previous reports suggested
it to be above 12.5e40.0 mL/cmH2O [4,5]. Bladder compliance
below this range is usually considered to indicate LCB. However, in
clinical practice, physicians are unable to read the bladder
compliance data from the screen while performing urodynamic
studies, and thus have to wait until the end of the study to inves-
tigate the data which are printed out in sheets. Fortunately, the end
ﬁlling detrusor pressure (EFP) could be a potential alternative in
this regard, which is easier to measure and does appear on cyst-
ometry more readily. Therefore, this study adopted an EFP greater
than 20 cmH2O, a cutoff commonly used in clinical practice, to
deﬁne LCB [6].by Elsevier Taiwan LLC. All rights reserved.
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the presence of neurological conditions, and thus the goal of this
study was to investigate the clinical signiﬁcance of LCB. For this
purpose, we collected and compared the correlation between
patients' clinical data and the results of videourodynamic studies
(VUSs).Materials and methods
Study design
A retrospective analysis was performed in 1490 women who
had received VUS to evaluate the cause of lower urinary tract
symptoms (LUTSs) between January 2005 and December 2010. All
the clinical data and VUS results were recorded in a prospective
setting using the same protocol. The main indications for VUS
included women with voiding dysfunction [8], urinary inconti-
nence [for womenwho failed to respond to conservative treatment
(e.g., medications, physiotherapy)], pelvic organ prolapse (POP;
greater than Stage II of the POP-Q system [9]), recurrent urinary
tract infection (RUTI), and neurogenic bladder. We deﬁned RUTI as
follows: either three or more symptomatic UTI episodes in the past
year or two such episodes in the past 6 months [10]. Neurogenic
bladder, which refers to dysfunction of the bladder due to disease of
the central nervous system or peripheral nerves, in our patients
most likely referred to women with diabetes mellitus (DM), a his-
tory of cerebrovascular accident, or spine surgery or radical
abdominal hysterectomy (RAH).
The Institutional Review Board of Chang-Gung Memorial Hos-
pital approved the chart evaluation of this retrospective study. In
brief, the study protocol is as follows: First, all patients underwent a
face-to-face structured interview that included questions related to
their age, parity, medical illness, and previous surgery. Drug history
was also obtained to exclude the cause that may aggravate the
symptoms. Physical examination included height, weight, and
pelvic examination to detect the presence of POP.
Digital examination and pinprick test were performed to assess
the S2eS4 dermatome. Patients with abnormal neurological sign
such as Babinski sign during pelvic examination or unsteady gait
were assessed for the underlying diseases. All women in the study
group had baseline assessment including urinalysis, postvoid re-
sidual (PVR) checked by an ultrasonic bladder scan (BVI 3000;
Diagnostic Ultrasound Corporation, Bothell, WA, USA), and a
bladder diary.
Second, in all cases only one physician (LHT) performed the VUS
throughout the study period using the same protocol (UD-2000;
Medical Measurement System, Enschede, The Netherlands), which
complied with the guidelines of the International Continence So-
ciety (ICS) [1], and all the terms used in this study followed the ICS
guidelines. A 4-Fr double lumen catheter (Medical Measurement
Systems) was inserted into the bladder and a 10-Fr rectal catheter
(Medtronic, Skovlunde, Denmark) was inserted into the rectum.
VUS was performed according to the standard protocol. Data on
VUS included uroﬂowmetry [maximum free ﬂow rate, voided vol-
ume (VV1), and PVR], ﬁlling cystometry [ﬁrst desire, maximum
cystometric capacity (MCC), and EFP], and voiding cystometry
[maximum ﬂow rate (Qmax), detrusor pressure at maximum ﬂow
(VP), and voided volume (VV2)].
Uroﬂowmetry, ﬁlling, and voiding cystometry were performed
using a Dantec Menuet (Dantec Medical A/S, Skovlunde, Denmark)
multichannel urodynamic machine in combination with a C-arm
imaging system (GE OEC 9800). All data were recorded and
analyzed using the Dantec Menuet (Dantec Medical A/S) multi-
channel urodynamic machine.Statistical analysis
Values were presented as mean ± standard deviation. All vari-
ables were tested for normal distribution using the Kolmogor-
oveSmirnov test. The Student t test was used to compare themeans
of continuous variables and normally distributed data; otherwise,
the ManneWhitney U test was used. Categorical data were tested
using the Chi-square test on the variables that evaluated differences
between groups as appropriate. The risk factors for LCB were
assessed by univariate analysis initially. The statistically signiﬁcant
(p < 0.05) variables obtained by the univariate analysis were used
for multivariate analysis. Multivariate analysis was performed by
multiple logistic regression applied based on forward data elimi-
nation. Calibration was assessed using the HosmereLemeshow
goodness-of-ﬁt test (C statistic). Discrimination was assessed using
the area under a receiver operating characteristic curve (AUROC).
Areas under two AUROC curves were compared by a nonparametric
approach. Finally, the cutoff point was calculated by acquiring the
best Youden index (sensitivity þ speciﬁcity e 1) [11], which is a
global measure of a test performance used for the evaluation of
overall discriminative power of a diagnostic procedure and for
comparison of this test with other tests. All statistical tests were
two-tailed and data were analyzed using SPSS 19.0 for Windows
software (SPSS, Inc., Chicago, IL, USA). A value of p < 0.05 was
considered signiﬁcant.
Results
Patient characteristics
Of the 1490 VUS performed consecutively, 136 women [9.1%
(mean age 56; mean parity 3)] diagnosed as a case of LCB based on
our deﬁnition (i.e., EFP > 20 cmH2O) were chosen for further
analysis. Among the study patients (n ¼ 1490), 939 (63%) were
postmenopausal women. The main indications for VUS included
women with voiding dysfunctions (385, 25.8%), urinary inconti-
nence (374, 25.1%), POP (275, 18.5%), RUTI (171, 11.5%), and neuro-
genic bladder (285, 19.1%). Table 1 presents patients' demographic
data and the clinical characteristics of LCB.Women in the LCB group
seemed to have higher residual urine (168mL vs.104mL, p < 0.001)
and higher prevalence of RUTI (22.3% vs. 11.5%, p < 0.001). They
were also more likely to have received the intermittent catheteri-
zation program (ICP) (12.5% vs. 10.4%, p < 0.001); besides, the
incidence of vesicoureteral reﬂux (VUR) was also higher in this
group (12.2% vs. 9.7%, p < 0.001).
The risk factors for LCB were assessed by univariate analysis
initially. Using multivariate analysis, the following were identiﬁed
as prognostic factors with a statistical signiﬁcance (Table 2): age
(p ¼ 0.005), MCC (p ¼ 0.002), EFP (p ¼ 0.028), detrusor overactivity
(DO; p ¼ 0.001), POP (p ¼ 0.018), RUTI (p ¼ 0.001), and RAH
(p < 0.001). Furthermore, we found that MCC, EFP, RUTI, and RAH
have a positive correlation with the LCB, whereas age, POP, and DO
have a negative correlation with the LCB.
The logarithm of odds of LCB is as follows: 1.094e0.018  age þ
0.001MCCþ 0.003 EFPþ 0.471 RUTI 0.475 DOþ 1.144
RAH þ 0.599  POP
Calibration and discrimination for illness scoring systems
The illness scoring systems (ISSs) can be used to compare groups
of patients in research trials or predict mortality and prognosis for
individuals and groups. The ISS can also measure physiological
variables derived from logistic regression from large demographic
data sets as in our study. The ISSs provide calibrated and validated
data, high level of discrimination, and can also indicate prognosis
Table 1
Demographic data and clinical characteristics of all study patients and those in the LCB group.
All patients (n ¼ 1490) LCB (n ¼ 136) p
Age (y) 60.39 ± 12.47 56.01 ± 14.36 0.001
Body height (cm) 154.78 ± 7.59 154.23 ± 5.49 0.55
Body weight (kg) 56.36 ± 12.15 56.88 ± 8.30 0.001
Parity 3.07 ± 1.54 3.48 ± 1.88 0.146
Maximum ﬂow rate (mL/s) 19.45 ± 8.24 15.3 ± 8.09 0.001
VV1 (mL) 330.75 ± 87.52 265.99 ± 160.63 0.701
PVR (mL) 104.29 ± 130.66 167.91 ± 195.81 <0.001
First desire (mL) 226.06 ± 17.26 409.98 ± 211.14 <0.001
MCC (mL) 433.51 ± 43.22 530.69 ± 215.19 <0.001
EFP (cmH2O) 15.02 ± 7.54 48.67 ± 95.58 <0.001
VP (cmH2O) 37.51 ± 11.28 47.70 ± 27.00 <0.001
Qmax (mL/s) 17.39 ± 7.11 13.27 ± 9.00 <0.001
VV2 (mL) 369.99 ± 115.43 359.66 ± 210.98 <0.001
POP 19.2% 4.0% <0.001
RUTI 11.5% 22.3% <0.001
ICP 10.4% 12.5% <0.001
VUR 9.7% 12.2% <0.001
DM 35.1% 11.0% 0.108
RAH 19.5% 11.3% <0.001
Data presented as mean ± standard deviation or percentages.
DM ¼ diabetes mellitus; EFP ¼ end ﬁlling detrusor pressure; ICP ¼ intermittent catheterization program; LCB ¼ low compliance bladder; MCC ¼ maximum cys-
tometric capacity; POP ¼ pelvic organ prolapse; PVR ¼ postvoid residual; Qmax ¼ maximum ﬂow rate; RAH ¼ radical abdominal hysterectomy; RUTI ¼ recurrent
urinary tract infection; VP ¼ detrusor pressure at maximum ﬂow; VUR ¼ vesicoureteral reﬂux; VV1 ¼ voided volume of uroﬂowmetry; VV2 ¼ voided volume of
voiding cystometry.
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measuring the overall goodness-of-ﬁt for predicting LCB risk and
the AUROC was used to assess the calibration and discrimination.
Table 3 and Figures 1 and 2 present the analytical results, which
indicate that age (p¼ 0.002), MCC (p < 0.001), EFP (p < 0.001), RUTI
(p < 0.001), POP (p < 0.001), DO (p < 0.001), and RAH (p < 0.001)
were strongly correlated with LCB risk. The results are presented in
two ﬁgures because it is not possible to show all predictors in one
ﬁgure: Figure 1 shows the discrimination power of age, POP, and
DO, which are negative predictors of LCB; Figure 2 shows theTable 2
The logistic regression for LCB risk factor prediction.
Parameter Beta coefﬁcient Stan
Univariate logistic regression
Age (y) 0.026 0.00
Body weight (cm) 0.039 0.01
Maximum ﬂow rate (mL/s) 0.055 0.01
PVR (mL) 0.005 0.00
MCC (mL) 0.002 0.00
EFP (cmH2O) 0.082 0.00
VP (cmH2O) 0.019 0.00
First desire (mL) 0.004 0.00
Qmax (mL/s) 0.071 0.01
POP 1.509 0.30
RUTI 1.886 0.22
ICP 2.118 0.30
VUR 1.486 0.26
DO 1.268 0.21
RAH 3.867 0.48
HTN 0.563 0.21
Multivariate logistic regression
Age (y) 0.051 0.01
MCC (mL) 0.003 0.00
EFP (cmH2O) 0.006 0.00
POP 1.410 0.59
RUTI 1.569 0.47
DO 1.616 0.47
RAH 4.467 1.14
Constant 0.095 1.09
CI ¼ conﬁdence interval; DO ¼ detrusor overactivity; EFP ¼ end ﬁlling detrusor press
MCC ¼ maximum cystometric capacity; POP ¼ pelvic organ prolapse; PVR ¼ postvoid
infection; VP ¼ detrusor pressure at maximum ﬂow; VUR ¼ vesicoureteral reﬂux.discrimination power of MCC, EFP, RUTI, and RAH, which are pos-
itive predictors of LCB. Negative predictors will cause the ROC curve
to lie under the diagonal line (line of no-discrimination) [12] and
these are considered as poor predictors (but in fact, they could be
good predictors as “negative predictors”). However, the output of a
consistently poor predictor could simply be inverted to obtain a
good predictor, and therefore in case of factors with negative pre-
dicting powers, simply inverting their decisions leads to a new
predictive method, which are mirrors according to the line of no-
discrimination and this mirrored method simply reverses thedard error Odds ratios (95% CI) p
8 0.957 (0.960e0.989) 0.001
2 0.962 (0.939e0.985) 0.001
8 0.946 (0.914e0.980) 0.002
1 1.005 (1.003e1.006) <0.001
1 1.002 (1.001e1.003) < 0.001
9 1.086 (1.066e1.105) <0.001
5 1.109 (1.010e1.028) <0.001
1 1.004 (1.002e1.005) <0.001
6 0.931 (0.903e0.960) <0.001
3 0.221 (0.122e0.401) <0.001
4 6.592 (4.248e10.228) <0.001
0 8.315 (4.623e14.955) <0.001
1 4.420 (2.652e7.368) <0.001
8 0.281 (0.184e0.431) <0.001
3 47.802 (18.546e123.211) <0.001
3 0.569 (0.375e0.864) 0.008
8 0.950 (0.917e0.985) 0.005
1 1.003 (1.001e1.006) 0.002
3 1.006 (1.001e1.012) 0.028
9 0.244 (0.076e0.789) 0.018
1 4.802 (1.907e12.095) 0.001
5 0.199 (0.078e0.504) 0.001
4 87.112 (9.251e820.282) 0.000
4 0.909 0.930
ure; ICP ¼ intermittent catheterization program; LCB ¼ low compliance bladder;
residual; RAH ¼ radical abdominal hysterectomy; RUTI ¼ recurrent urinary tract
Table 3
Assessment of the predictive value of each measurement, sensitivity, speciﬁcity, and overall correctness of prediction.
Possible risk factor of LCB Calibration Discrimination
HosmereLemeshow Chi square df p AUROC ±SE 95% CI p
POP 0.00 0 <0.001 0.619 ± 0.026 0.568e0.671 <0.001
RUTI 0.00 0 <0.001 0.700 ± 0.028 0.645e0.756 <0.001
DO 0.00 0 <0.001 0.651 ± 0.027 0.597e0.704 <0.001
RAH 0.00 0 <0.001 0.695 ± 0.030 0.637e0.754 <0.001
Age 5.442 8 0.709 0.592 ± 0.029 0.535e0.650 0.002
EFP 88.621 8 <0.001 0.960 ± 0.009 0.942e0.979 <0.001
MCC 5.683 0 0.683 0.647 ± 0.028 0.593e0.701 <0.001
AUROC¼ area under a receiver operating characteristic curve; CI¼ conﬁdence interval; DO¼ detrusor overactivity; EFP¼ end ﬁlling detrusor pressure; LCB¼ low compliance
bladder; MCC¼maximum cystometric capacity; POP¼ pelvic organ prolapse; RAH¼ radical abdominal hysterectomy; RUTI¼ recurrent urinary tract infection; SE¼ standard
error.
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us to compare discrimination powers between them with factors
listed in Figure 2.
EFP, calibration for EFP (HosmereLemeshow Chi-
square ¼ 88.621; p < 0.001), had the best predictive power. The
AUROC curve conﬁrmed the superior discrimination of the EFP
compared with other factors. To assess the predictive value,
sensitivity, speciﬁcity, and overall correctness of prediction, the
Youden index was calculated and the EFP was found to have the
best Youden index and the highest overall correctness of prediction
(Table 4). Table 4 shows the discrimination powers between age,
MCC, and EFP. The reason we listed these three factors is because
only continuous variables are effective predicting factors. The cutoff
points obtained are then analyzed by SPSS. According to the cutoff
point, when awoman has EFP greater than 17.5 cmH2O, she tends toFigure 1. Area under a receiver operating characteristic curve showing the discrimination
DO ¼ detrusor overactivity; POP ¼ pelvic organ prolapse; ROC ¼ receiver operating characdevelop LCB with a sensitivity and speciﬁcity of 89% and 92.7%,
respectively.
Discussion
We diagnosed 136womenwith LCB using our deﬁnition and our
study indicated that age, MCC, DO, POP, RUTI, and RAH as inde-
pendent prognostic factors; in addition, our study results show that
using EFP for screening women with LCB is feasible for clinical use.
According to the cutoff point, when a woman has EFP greater than
17.5 cmH2O, she tends to develop LCB with a sensitivity and spec-
iﬁcity of 89% and 92.7%, respectively.
We chose EFP instead of bladder compliance (DV/DP) because
we felt that this may be more practical for clinical use to deﬁne LCB
as it can be directly seen on the screen [6,13]. LCB may be caused bypower of age, POP, and DO, which are negative predictors of low compliance bladder.
teristic curve.
Figure 2. Area under a receiver operating characteristic curve showing the discrimination power of MCC, EFP, RUTI, and RAH, which are positive predictors of low compliance
bladder. EFP ¼ end ﬁlling detrusor pressure; MCC ¼ maximum cystometric capacity; RAH ¼ radical abdominal hysterectomy; RUTI ¼ recurrent urinary tract infection.
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muscle tone change [14], or both. It is not surprising that EFP in-
creases in women with LCB, which can be attributed to the
decreasing dispensability of the bladder. Data for bladder compli-
ance in urology are sparse and even less in urogynecology [4,5,7].
The most recent study on this issue was conducted by Cho et al in
2009 [7]. The criterion they used for LCB was 10mL/cmH2O and LCB
was diagnosed in 170 (3.4%) cases (76 males and 94 females) in
their study. They also found that LCB was correlated with the
presence of neurological conditions and a history of pelvic irradi-
ation or radical prostatectomy. The incidence of VUR in their study
was 1.93% (1.7e2.4%) in female patients. By contrast, our study
focuses on women with LUTS and the incidence of VUR was found
to be higher (9.7%). This rate was even higher in patients in the LCB
group (12.2%). We found that age, MCC, EFP, DO, POP, RUTI, and RAH
were strongly correlated with the risk of LCB and a cutoff value was
obtained for clinical implication. Harris et al [5] reported their
experience concerning bladder compliance in neurologically intact
women and their data showed that 95% of neurologically intact
women have bladder compliance greater than 40 mL/cm; but, if we
use the current concept (MCC of 400e600 mL) [15], then the EFPTable 4
Assessment of the discrimination power between age, MCC and EFP.
Predictive factors of LCB Cutoff point Youden index
Age 61.5 0.159
MCC 503.5 0.218
EFP 17.5 a 0.817
EFP ¼ end ﬁlling detrusor pressure; LCB ¼ low compliance bladder; MCC ¼ maximum c
a Value giving the best Youden index.will range from 10 (400/40) cmH2O to 12.5 (600/40) cmH2O.
However, their data did not offer much clinical information about
LCB. Because LCB might have an impact on quality of life and in
particular may cause upper urinary tract damage, we wanted to
ﬁnd a clinically useful tool to delineate LCB using objective data.We
also wanted to ﬁnd out a cutoff value of EFP to offer clinicians a
valuable tool to assess LCB. However, we could not ﬁnd sufﬁcient
studies discussing about the relationship between EFP and LCB.
Recently, Gray [16] deﬁned the concept of bladder wall compliance,
discussed various methods of measuring or assessing compliance,
and reviewed its clinical relevance. Based on existing evidence,
Gray [16] noted that low bladder wall compliance is attributable to
increased detrusor muscle tone during bladder ﬁlling or changes in
the viscoelastic properties of the bladder wall that impede the
ability of the bladder wall to stretch. The author also indicated that
low bladder wall compliance is clinically relevant because of its
potential to produce upper urinary tract damage, and there is an
increased risk of febrile urinary tract infections, hydronephrosis,
VUR, renal scarring, compromised urinary tract function, and uri-
nary incontinence because of its direct inﬂuence on the bladder
outlet. In addition, low bladder wall compliance is associatedwith aSensitivity (%) Speciﬁcity (%) Overall correctness (%)
50.4 65.4 47.7
52.9 68.9 65.44
89.0 92.7 88.97
ystometric capacity.
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bladder dysfunction, pelvic irradiation, interstitial cystitis, and
likely, in our case, RAH.
Our study also indicates that RAH (p < 0.001) is a prognostic
factor (positive predictor) with a statistical signiﬁcance for LCB. The
possible impact on bladder function may be, during RAH, inter-
ruption of pelvic nerves and fascial structures in the anterior,
posterior, and lateral parametrium, which eventually leads to
various degrees of bladder dysfunction [17]. In a recent review,
Plotti et al [17] reported the overall incidence of urodynamic
bladder dysfunctions to be 72%; in particular, the incidence rates of
detrusor dysfunctions (with high or low compliance), mixed uri-
nary incontinence, and stress urinary incontinence were reported
to be 42%, 24.5%, and 40%, respectively. Concerning detrusor dys-
functions, the studies reviewed by Plotti et al [17] reported a high
incidence of DO (34%) associated with low compliance. Besides,
their review also indicated a decrease in the maximal urethral
closure pressure between the preoperative analysis and post-
operative analysis. They also tried to explain the reasons for various
bladder dysfunctions after RAH, which included impaired urethral
pressure (possibly related to the damage of the pelvic plexus and
pudendal nerveswith loss of periurethral zone) [18], high incidence
of DO, and urinary stress incontinence (the loss of sympathetic
alpha-adrenergic stimulation due to surgical damage, which may
have an excitatory effect on parasympathetic transmission to the
detrusor muscle during urine storage and lead to permanent
relaxation of the bladder neck and the proximal urethra) [19].
Our study indicates that RUTI (p ¼ 0.001) is a prognostic factor
(positive predictor) with a statistical signiﬁcance for LCB, which
means that if a woman gets more UTI, bladder compliance will get
worse. In our study, women in the LCB group had higher prevalence
of UTI (22.3% vs. 11.5%, p < 0.001) among thewhole study group and
we believe that this is due to the synergistic effect of UTI and LCB.
UTI in itself will increase intravesical pressure [20] and by
damaging the urothelium or bladder lining, the viscoelastic prop-
erties of the bladder, based on its composition of smooth muscle,
collagen, and elastin, could be impaired. The bladder eventually
losses the ability to store urine during normal bladder ﬁlling,
leading to reduced bladder compliance. In addition, UTI weakens
the urethrovesical junction, predisposing to reﬂux [21].
Our study indicates that MCC (p ¼ 0.002) is a prognostic factor
(positive predictor) with a statistical signiﬁcance for LCB, which
means that as the bladder capacity increases, bladder compliance
decreases and this is in contrast to our thinking because, based on
clinical observations, the bladder compliance should remain stable
during the ﬁlling phase for most women and LCB was diagnosed in
women with low-capacity bladder. MCC reﬂects the volume at
which a patient with normal bladder sensation can no longer delay
voiding, indicating that the bladder capacity has reached its
maximum and that normal voiding needs to be initiated. In this
study, based on ICS guidelines, MCC was deﬁned as the volume at
which the patient felt a strong urge to void and/or voided. For
patients who did not experience an urge to void, we just stopped
bladder ﬁlling at a bladder volume of 1000mL. An interesting study
by Purohit et al [22] tried to describe the pathophysiology, differ-
ential diagnosis, and urodynamic ﬁndings in patients with a large
capacity bladder (MCC 700 mL). A total of 56 men and 44 women
with a bladder capacity of 700e5013 mL were studied. LCB was
found in eight patients (8%), although the sex of these patients was
not indicated. The authors found that patients with LCB had a
higher Pdetmax than those with normal compliance and there were
no differences in Qmax, PdetQmax, PVR, or MCC between the two
patient groups. Five patients with LCB had bladder diverticula but
only one had hydronephrosis. By contrast, in our study, LCB was
found in 136 (9.1%) patients and our study data suggested thatwomen with LCB had a higher Pdetmax, MCC, PVR, and lower Qmax
than those with normal compliance. One article discussed urody-
namic ﬁndings in chronic renal failure patients [23] and found that
the mean detrusor compliance and detrusor capacity signiﬁcantly
decreased as the disease progressed.
Our study indicates the presence of POP (p ¼ 0.018) as a prog-
nostic factor (negative predictor) with a statistical signiﬁcance for
LCB, meaning that the more the POP, the lesser the chance of LCB.
However, we could not ﬁnd any article that addressed the relation
between POP and LCB. Most published articles on urodynamic
ﬁndings in women with POP mainly focused on preoperative/
postoperative comparisons and only a few of them discussed the
relation between urodynamic ﬁndings and POP. A recent study
conducted by Serati et al [8] offered valuable information regarding
this issue. The authors found that POP quantiﬁcation stages and
baseline data were poorly correlated with ﬁnal urodynamic ﬁnd-
ings; in addition, both urinary stress incontinence and overactive
bladder were independently associated with each urodynamic
studies (UDS) diagnosis, including DO, urodynamic stress inconti-
nence (USI), and mixed urinary incontinence (USI plus DO). How-
ever, the authors recommended that urodynamic study plays a key
role in preoperative counseling of women scheduled for pelvic
reconstructive procedures to reveal particular conditions, such as
occult USI or in patients in whom DO represents the underlining
condition of overactive bladder. Araki et al [24] also reported that
the presence of DO was a good predictor of postoperative persis-
tence of urgency and urge urinary incontinence in women with
POP; in addition, poor detrusor contractility was reported as the
best predictor of large PVR occurrence [24].
Our study results indicate that age (p ¼ 0.005) is a prognostic
factor (negative predictor) with a statistical signiﬁcance for LCB,
indicating that older women are signiﬁcantly less likely to have LCB,
and this again is in contrast to our thinking. The pathophysiological
change of aging is a broad-spectrum issue and aging is associated
with declining function in almost every physiological system. In the
urinary system, LUTSs aremore frequent among elderly individuals,
and urodynamic studies demonstrate the relationship between
aging and reduced bladder capacity, uninhibited contractions,
decreased urinary ﬂow rate, and increased PVR volume [25].
Several mechanisms including collagen deposition [26], loss of
acetylcholinesterase-positive nerve terminals [27], detrusor
ﬁbrosis, and impaired contractility have been proposed in this re-
gard. Althoughmany clinical studies agree that aging has an impact
on LCB, it is hard to understand whether the pathogenesis is mainly
caused only by aging or any other underlying disease (such as DM
or others causing neuropathies involving micturition reﬂex).
Our study results indicate that the presence of DO (p ¼ 0.001) is
a prognostic factor (negative predictor) with a statistical signiﬁ-
cance for LCB, meaning womenwith DO are signiﬁcantly less likely
to have LCB. However, we could not ﬁnd any article that addressed
the relation between DO and LCB because some physicians might
treat both of these conditions using the same antimuscarinic
agents. In women with DO, the bladder may experience general-
ized, nerve-mediated excitation of the detrusor or a combination of
spontaneous excitation within smooth muscle and an enhanced
prolongation to excite the bladder wall [28], which shows up
involuntary contractions in the cystometric ﬁndings. Theoretically,
in women with DO, involuntary contractions are more likely or
earlier to occur during ﬁlling because of the prolongation of bladder
wall excitation, and thus the patient can no longer delay micturi-
tion. Some studies have demonstrated the inverse relationship
between severity of bladder overactivity and bladder capacity [29].
MCC is widely regarded as an important tool to judge the severity of
the DO [30], but it is not recognized as a tool for DO predictions
so far.
J.-Y. Liao et al. / Taiwanese Journal of Obstetrics & Gynecology 54 (2015) 709e715 715Despite these encouraging results, this study has some limita-
tions. This is a retrospective study from a single tertiary medical
center, and therefore it may not have much persuasiveness in
generalization, and a selection bias associated with a hospital-
based study may exist. The actual association between LCB and
predictive factors is yet to be fully understood. However, all of the
clinical data and VUS results in this study were recorded in a pro-
spective setting with a uniform protocol using a real-time elec-
tronic data recording system. In addition, because our study
focused on women with LCB, only 136 patients with voiding difﬁ-
culty and prolapse, rather than a general group which had baseline
urodynamics, were chosen among those who required VUS
(n ¼ 1490). Thus, future studies should recruit additional patients
to present more powerful results.
In conclusion, we investigated the clinical signiﬁcance of LCB in
women with LUTS and tried to use EFP as a tool to predict and
distinguish women who might develop LCB. Our study results
indicate that EFP can be used as a screening tool and we even
identiﬁed a cutoff point for EFP (17.5 cmH2O). Nevertheless, the data
presented do not establish the precise cause nor the incidence and
these results are very preliminary, and therefore further studies are
needed to substantiate the clinical utility of these methods.
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